Your browser is no longer supported. Please, upgrade your browser.
SOLY Soliton, Inc. monthly Stock Chart
SOLY [NASD]
Soliton, Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own5.60% Shs Outstand14.48M Perf Week-41.04%
Market Cap90.50M Forward P/E- EPS next Y- Insider Trans- Shs Float5.20M Perf Month-49.15%
Income-10.60M PEG- EPS next Q- Inst Own0.90% Short Float5.24% Perf Quarter28.86%
Sales- P/S- EPS this Y-29.10% Inst Trans- Short Ratio1.22 Perf Half Y-
Book/sh-9.79 P/B- EPS next Y- ROA-879.50% Target Price- Perf Year-
Cash/sh0.01 P/C905.00 EPS next 5Y- ROE66.40% 52W Range4.12 - 15.00 Perf YTD28.34%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-58.33% Beta-
Dividend %- Quick Ratio0.00 Sales past 5Y- Gross Margin- 52W Low51.70% ATR1.41
Employees7 Current Ratio0.00 Sales Q/Q- Oper. Margin- RSI (14)31.67 Volatility20.42% 12.72%
OptionableNo Debt/Eq- EPS Q/Q-43.70% Profit Margin- Rel Volume0.80 Prev Close6.42
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume224.02K Price6.25
Recom- SMA20-44.08% SMA50-37.60% SMA200-29.44% Volume178,281 Change-2.65%
May-17-19 11:57AM  Soliton Responds To Blog Calling It A 'PR Machine' Benzinga
08:00AM  Soliton Provides FDA Update and Addresses Recent Anonymous Article PR Newswire
May-16-19 08:00AM  Soliton's RAP Device Able to Penetrate Vacuole Shielding; Targets $4 Billion Potential Tattoo Removal Market PR Newswire -31.50%
May-14-19 02:39PM  Biotech Brief: Most Recent Technological Advancements Pushing U.S. Medical Device Market to New Levels PR Newswire -6.94%
08:30AM  Soliton Receives Approval for New Patent for its Acoustic Shockwave Technology PR Newswire
May-13-19 05:05PM  Fighting cellulite and removing tattoos with sound waves Yahoo Finance Video -16.25%
10:31AM  Global market to combat cellulite to reach $1.4B by 2026 Yahoo Finance Video
May-09-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire +6.76%
May-01-19 08:00AM  Soliton Announces Completion of New Replaceable Cartridge to Target Cellulite Reduction PR Newswire +6.73%
Apr-23-19 08:00AM  Soliton Announces Global Partner Completes Second Generation RAP Device to More Effectively Target Cellulite Reduction PR Newswire +11.64%
Apr-18-19 08:00AM  Soliton to be Featured on Yahoo Finance's 'The First Trade' Show on May 13, 2019 to Discuss Cellulite Trial Results PR Newswire -9.99%
Apr-15-19 08:00AM  Soliton Announces Cellulite Trial Results to be Presented at National Aesthetics Conference on May 11, 2019 PR Newswire +14.55%
Apr-09-19 08:00AM  Soliton Completes Cellulite Clinical Trials PR Newswire
Apr-04-19 08:00AM  Soliton Receives European Patent for Acoustic Shockwave Technology PR Newswire +11.11%
Apr-01-19 08:00AM  Soliton Initiated Clinical Trials for Treatment of Cellulite in Humans PR Newswire +10.74%
Mar-27-19 08:00AM  Soliton Receives FDA Acceptance for 510(k) Application PR Newswire
Mar-21-19 08:00AM  Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device PR Newswire +8.16%
Mar-19-19 08:00AM  Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication PR Newswire +17.55%
Mar-18-19 08:00AM  Soliton to Present at Oppenheimer 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-14-19 08:00AM  Soliton Partners with Sanmina, a Global Medical Device Manufacturer ACCESSWIRE +10.00%
Mar-12-19 08:00AM  Soliton to Ring the Nasdaq Stock Market Closing Bell on March 19, 2019 ACCESSWIRE
Mar-08-19 08:00AM  Soliton's RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation ACCESSWIRE
Mar-04-19 07:00AM  Soliton Receives FDA Approval for Small Business Designation ACCESSWIRE
Feb-28-19 07:00AM  Soliton Discusses Rapid Acoustic Pulse Technology for Treatment of Cellulite GlobeNewswire +6.85%
Feb-26-19 07:30AM  Soliton Receives Additional Patent for Breakthrough Acoustic Shockwave Technology GlobeNewswire
Feb-19-19 12:03PM  Soliton, Inc. Completes IPO and Begins Trading on Nasdaq Under Ticker Symbol SOLY GlobeNewswire
Soliton, Inc., an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.